|
|
| (175 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | + | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32335367|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Respiration mgmt]]''' |
| | + | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | + | |
| | + | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | + | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | + | |
| | + | |
| | | | |
| − | *'''[[Research tools]]'''
| |
| − | {{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}}
| |
| − | {{tp|p=32187834|t=2020. ..COVID19: Cytometry and the New Challenge for Global Health |pdf=|usr=}}
| |
| | | | |
| − | *
| |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32311462|t=2020. On the molecular determinants of the SARS-CoV-2 attack |pdf=|usr=}}
| |
| − | {{tp|p=32129843|t=ä. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients |pdf=|usr=}}
| |
| − | {{tp|p=32129842|t=ä. A glimpse into the origins of genetic diversity in SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32229288|t=ä. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32341946|t=2020. Chaos game representation dataset of SARS-CoV-2 genome |pdf=|usr=}}
| |
| − | {{tp|p=32301390|t=2020. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| − | {{tp|p=32220422|t=2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32271376|t=ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19 |pdf=|usr=}}
| + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | + | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
| |
| − | {{tp|p=32368728|t=ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| Zeile 36: |
Zeile 39: |
| | | | |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Pathobiology]]''' |
| − | * | + | |
| | + | |
| | + | *'''[[Disease Models]]''' |
| | + | |
| | + | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | *'''[[Early symptoms]]''' | | *'''[[Early symptoms]]''' |
| | + | |
| | *'''[[Systemic disease, any manifestations]]''' | | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32160148|t=2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China |pdf=|usr=}}
| |
| − | {{tp|p=32343223|t=2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient |pdf=|usr=}}
| |
| − | {{tp|p=32298228|t=2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| − |
| |
| − | *'''[[ARDS]]'''
| |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32334995|t=2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32348233|t=2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| − | {{tp|p=32178975|t=ä. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Heart]]'''
| |
| − | {{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}}
| |
| − | {{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}}
| |
| − | {{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}}
| |
| − | {{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32283980|t=2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms |pdf=|usr=}}
| |
| − | {{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32347027|t=2020. Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports |pdf=|usr=}}
| |
| − | {{tp|p=32347435|t=ä. SARS-CoV-2-Induced Vomiting as Onset Symptom in a Patient with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32285321|t=ä. A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32150527|t=2020. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]== | + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32299479|t=2020. Acute kidney injury in SARS-CoV-2 infected patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32197060|t=2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *
| |
| − | *'''[[Pathobiology]]'''
| |
| | | | |
| − | *'''[[Disease Models]]''' | + | *'''[[Dermatology]]''' |
| − | {{tp|p=32215622|t=ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility |pdf=|usr=}}
| + | |
| − | {{tp|p=32378471|t=2020. Animal models for emerging coronavirus: progress and new insights |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | *
| |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=32267220|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32357808|t=2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32294704|t=ä. Structured thoracic computed tomography report for COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32374802|t=ä. The halo sign as a chest computed tomography finding of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32241244|t=2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019 |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32360077|t=ä. Estimating severe and critical illness in children with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32311646|t=ä. COVID-19 admissions calculators: General population and paediatric cohort |pdf=|usr=}}
| |
| − | {{tp|p=32344199|t=2020. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs |pdf=|usr=}}
| |
| − | {{tp|p=32298856|t=2020. From the insight of glucose metabolism disorder: Oxygen therapy and blood glucose monitoring are crucial for quarantined COVID-19 patients |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Case reports]]''' |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32357995|t=2020. Tracheal intubation in patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32326959|t=2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=C7156900|t=2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| − | {{tp|p=32328575|t=ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32322805|t=ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV |pdf=|usr=}}
| |
| − | {{tp|p=32372857|t=2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know?? |pdf=|usr=}}
| |
| − | {{tp|p=32250244|t=2020. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32134381|t=2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China |pdf=|usr=}}
| |
| − | {{tp|p=32324118|t=2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32343659|t=2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32160149|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32337324|t=2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32267826|t=2020. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand |pdf=|usr=}}
| + | |
| | + | *'''[[Registries]]''' |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| | + | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32379923|t=2020. Is BCG vaccination causally related to reduced COVID-19 mortality?|pdf=|usr=}}
| |
| − | {{tp|p=32333818|t=2020. COVID-19: lambda interferon against viral load and hyperinflammation |pdf=|usr=}}
| |
| − | {{tp|p=32338155|t=2020. Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| − | *'''[[Biophysics of aerosols]]'''
| |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32241022|t=ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32297915|t=ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32243255|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations |pdf=|usr=}}
| + | *'''[[Biophysics of aerosols]]''' |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32324531|t=2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32284092|t=2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols |pdf=|usr=}}
| |
| | | | |
| − | *
| + | |
| | + | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32368727|t=ä. Testing for COVID-19 in patients with cancer |pdf=|usr=}}
| |
| − | {{tp|p=32292899|t=2020. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32342040|t=2020. Covid-19 and perioperative mortality; where do we stand?|pdf=|usr=}}
| |
| − | {{tp|p=32335416|t=2020. Coronavirus Disease 2019 (COVID-19) and dermatologists: Potential biological hazards of laser surgery in epidemic area?????? |pdf=|usr=}}
| |
| − | {{tp|p=32374801|t=ä. Fair allocation of scarce medical resources during COVID-19 pandemic: ethical considerations |pdf=|usr=}}
| |
| − | {{tp|p=32216872|t=2020. Mitigating the impact of conference and travel cancellations on researchers? futures |pdf=|usr=}}
| |
| − | {{tp|p=32209226|t=2020. Publishing in the time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32308195|t=2020. Improving on legacy conferences by moving online |pdf=|usr=}}
| |
| − | {{tp|p=32241814|t=2020. Emergency departments and the COVID-19 pandemic: making the most of limited resources |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32248083|t=2020. Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution |pdf=|usr=}}
| |
| − | {{tp|p=32229646|t=2020. Staff Mental Health Self-Assessment During the COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32368726|t=ä. COVID-19 and Healthcare worker s families: behind the scenes of frontline response |pdf=|usr=}}
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32314954|t=ä. COVID-19 Community Stabilization and Sustainability Framework: An Integration of the Maslow Hierarchy of Needs and Social Determinants of Health |pdf=|usr=}}
| |
| − | {{tp|p=32274787|t=2020. Psychische Probleme in der Pandemie - Beobachtungen wahrend der COVID-19-Krise |pdf=|usr=}}
| |
| − | {{tp|p=32292900|t=2020. COVID-19: Reducing the risk of infection might increase the risk of intimate partner violence |pdf=|usr=}}
| |
| − | {{tp|p=32202993|t=2020. Public Mental Health Crisis during COVID-19 Pandemic, China |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 189: |
Zeile 131: |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32339092|t=2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore |pdf=|usr=}}
| + | |
| − | {{tp|p=32339091|t=2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | + | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| | + | |
| | + | |
| | *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
| − | *
| + | ---- |
| | + | |
| | + | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| | + | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32315281|t=2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32315626|t=2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| − | {{tp|p=32377635|t=ä. Pandemic-related excess mortality (COVID-19), public health measures and funerary rituals |pdf=|usr=}}
| |
| − | {{tp|p=32292897|t=2020. A systems approach to preventing and responding to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32292898|t=2020. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures |pdf=|usr=}}
| |
| − | {{tp|p=32313879|t=ä. What are the Underlying Transmission Patterns of COVID-19 Outbreak? ? An Age-specific Social Contact Characterization |pdf=|usr=}}
| |
| − | {{tp|p=32091395|t=2020. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32275804|t=2020. Why does Japan have so few cases of COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32375201|t=2020. All In : A Pragmatic Framework for COVID-19 Testing and Action on a Global Scale |pdf=|usr=}}
| |
| − | {{tp|p=32259394|t=2020. COVID-19, chronicle of an expected pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32301279|t=2020. The prospects for the SARS-CoV-2 pandemic in Africa |pdf=|usr=}}
| |
| − | {{tp|p=32181577|t=2020. The spread of the COVID?19 coronavirus: Health agencies worldwide prepare for the seemingly inevitability of the COVID?19 coronavirus becoming endemic |pdf=|usr=}}
| |
| − | {{tp|p=32364890|t=2020. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic |pdf=|usr=}}
| |
| − | {{tp|p=32091386|t=2020. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32228809|t=2020. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China |pdf=|usr=}}
| |
| − | {{tp|p=32228808|t=2020. Policy Decisions and Use of Information Technology to Fight 2019 Novel Coronavirus Disease, Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32207679|t=2020. Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions |pdf=|usr=}}
| |
| − | {{tp|p=32197059|t=2020. Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe |pdf=|usr=}}
| |
| − | {{tp|p=32187007|t=2020. Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32191173|t=2020. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases |pdf=|usr=}}
| |
| − | {{tp|p=32168465|t=2020. Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32168464|t=2020. Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32168463|t=2020. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality |pdf=|usr=}}
| |
| − | {{tp|p=32163030|t=2020. Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32125269|t=2020. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32118533|t=2020. COVID-19 in 2 Persons with Mild Upper Respiratory Symptoms on a Cruise Ship, Japan |pdf=|usr=}}
| |
| − | {{tp|p=32343222|t=2020. Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease |pdf=|usr=}}
| |
| − | {{tp|p=32255761|t=2020. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32330410|t=2020. Doubling Time of the COVID-19 Epidemic by Province, China |pdf=|usr=}}
| |
| − | {{tp|p=32330112|t=2020. Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32324530|t=2020. Coronavirus Disease Outbreak in Call Center, South Korea |pdf=|usr=}}
| |
| − | {{tp|p=32320641|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Potential, Iran, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32315282|t=2020. Estimation of Coronavirus Disease Case-Fatality Risk in Real Time |pdf=|usr=}}
| |
| − | {{tp|p=32240079|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32240078|t=2020. COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32298227|t=2020. Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong |pdf=|usr=}}
| |
| − | {{tp|p=32275498|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32275497|t=2020. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32338150|t=2020. Mathematic modeling of COVID-19 in the United States |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | *'''[[Remission, recurrence and persistence]]''' |
| − | {{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}}
| + | |
| − | {{tp|p=32292239|t=2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis |pdf=|usr=}}
| + | |
| − | {{tp|p=32252845|t=ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | + | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | + | |
| | + | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}}
| + | |
| − | {{tp|p=32241328|t=ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| | + | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | + | ---- |
| | + | |
| | + | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | *'''[[Current state of coviki.org]]'''
| |
| − | *[[PubMed selected papers unsorted to be listed in contents topics]]
| |
| − | *[[coviki state of development]]
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32283498|t=2020. COVID-19: From bench to bed side |pdf=|usr=}}
| + | |
| − | {{tp|p=32313668|t=2020. COVID-19: A new digital dawn?|pdf=|usr=}}
| + | |
| − | {{tp|p=32252856|t=ä. Is There a Guarantee That the Crisis of COVID-19 Will not Be Repeated?|pdf=|usr=}}
| + | *'''[[Research tools]]''' |
| − | {{tp|p=32241329|t=ä. Global Health Security Alliance (GloHSA) |pdf=|usr=}}
| + | |
| − | {{tp|p=32360076|t=ä. Fatherhood during the COVID-19 pandemic: an unexpected turnaround |pdf=|usr=}} | + | |
| − | {{tp|p=32228860|t=2020. SARS-CoV-2 (COVID-19) by the numbers |pdf=|usr=}} | + | |
| − | {{tp|p=32337502|t=ä. A reality check on the use of face masks during the COVID-19 outbreak in Hong Kong |pdf=|usr=}}
| + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | + | |
| − | *[http://www.reactionbiology.com 700 kinsse assays] | + | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
